Login / Signup

Editorial: IBD cost evolution - transitioning from compensating lost productivity to escalating medication expenses.

Ashkan Rezazadeh ArdabiliAdriaan A van Bodegraven
Published in: Alimentary pharmacology & therapeutics (2023)
Keyphrases
  • climate change
  • adverse drug
  • healthcare
  • ulcerative colitis
  • electronic health record